MS Society asks Ottawa for $10-million to research controversial treatment

The Multiple Sclerosis Society of Canada is asking Ottawa to put $10-million into researching a new and controversial way of treating some MS patients.

Chronic Cerebrospinal venous insufficiency (CCSVI) has been shown in limited studies to help patients with one form of MS, but more research is needed.

The request for funding comes as Canadians with MS continue to seek diagnostics and treatment for CCSVI in other countries, paying out-of-pocket for tests and experimental therapies that could be provided in Canada.

Last year the MS Society of Canada announced a special research competition and extra funding for CCSVI-related studies. The results of this competition will be announced June 14.